Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 13, Issue 3, Pages 235-245
Publisher
Informa UK Limited
Online
2016-08-24
DOI
10.1080/1744666x.2016.1226132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase Ib/II, dose-escalating, safety, and efficacy study of imprime PGG and cetuximab in patients with advanced colorectal cancer (CRC).
- (2017) M. B. Tamayo et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract 3280: Imprime PGG synergizes with anti-angiogenic antibodies to repolarize the immune microenvironment, suppressing xenograft tumor growthin vivo
- (2016) Kathryn Fraser et al. CANCER RESEARCH
- Abstract LB-080: Imprime PGG, a β-glucan PAMP (pathogen-associated molecular pattern) activates the direct killing functions of innate immune cells in concert with tumor targeting antibodies
- (2016) Steven M. Leonardo et al. CANCER RESEARCH
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
- (2015) Joseph P. Balint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
- (2014) J. Goldstein et al. ANNALS OF ONCOLOGY
- Is the "3+3" Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design
- (2014) O. E. Rahma et al. CLINICAL CANCER RESEARCH
- Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients
- (2014) Daiqing Gao et al. PLoS One
- TroVax in colorectal cancer
- (2014) Julie Rowe et al. Human Vaccines & Immunotherapeutics
- Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
- (2014) S. Kibe et al. Cancer Immunology Research
- Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
- (2013) Michael A. Morse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer
- (2011) V. A. de Weger et al. CLINICAL CANCER RESEARCH
- Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review
- (2011) Benqiang Rao et al. Journal of Translational Medicine
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
- (2011) Neil Senzer et al. MOLECULAR THERAPY
- Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients
- (2010) Richard Harrop et al. JOURNAL OF IMMUNOTHERAPY
- The mutation spectrum revealed by paired genome sequences from a lung cancer patient
- (2010) William Lee et al. NATURE
- Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis
- (2010) Bernd Timmermann et al. PLoS One
- Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
- (2009) M Koopman et al. BRITISH JOURNAL OF CANCER
- Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients
- (2009) Takashi Hattori et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
- (2009) H. C. Toh et al. CLINICAL CANCER RESEARCH
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
- (2008) H. L. Kaufman et al. CLINICAL CANCER RESEARCH
- Molecular biology of inflammation and sepsis: A primer*
- (2008) Ismail Cinel et al. CRITICAL CARE MEDICINE
- An MVA-based Vaccine Targeting the Oncofetal Antigen 5T4 in Patients Undergoing Surgical Resection of Colorectal Cancer Liver Metastases
- (2008) Eyad Elkord et al. JOURNAL OF IMMUNOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More